JP7808424B2 - 修飾されたl-アスパラギナーゼ - Google Patents

修飾されたl-アスパラギナーゼ

Info

Publication number
JP7808424B2
JP7808424B2 JP2019571042A JP2019571042A JP7808424B2 JP 7808424 B2 JP7808424 B2 JP 7808424B2 JP 2019571042 A JP2019571042 A JP 2019571042A JP 2019571042 A JP2019571042 A JP 2019571042A JP 7808424 B2 JP7808424 B2 JP 7808424B2
Authority
JP
Japan
Prior art keywords
asparaginase
modified protein
amino acid
seq
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019571042A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2018234492A5 (https=
JP2020528743A (ja
JP2020528743A5 (https=
Inventor
フリードリヒ,ラース
オドネル,アン
Original Assignee
ジャズ ファーマシューティカルズ アイルランド リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP17177237.9A external-priority patent/EP3418383A1/en
Priority claimed from US15/671,086 external-priority patent/US10174302B1/en
Application filed by ジャズ ファーマシューティカルズ アイルランド リミテッド filed Critical ジャズ ファーマシューティカルズ アイルランド リミテッド
Publication of JP2020528743A publication Critical patent/JP2020528743A/ja
Priority to JP2023030460A priority Critical patent/JP7770352B2/ja
Publication of JPWO2018234492A5 publication Critical patent/JPWO2018234492A5/ja
Publication of JP2020528743A5 publication Critical patent/JP2020528743A5/ja
Application granted granted Critical
Publication of JP7808424B2 publication Critical patent/JP7808424B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/78Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • C12N9/82Asparaginase (3.5.1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y305/00Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/01Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amides (3.5.1)
    • C12Y305/01001Asparaginase (3.5.1.1)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP2019571042A 2017-06-21 2018-06-21 修飾されたl-アスパラギナーゼ Active JP7808424B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023030460A JP7770352B2 (ja) 2017-06-21 2023-02-28 修飾されたl-アスパラギナーゼ

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201762523061P 2017-06-21 2017-06-21
EP17177237.9A EP3418383A1 (en) 2017-06-21 2017-06-21 Modified l-asparaginase
EP17177237.9 2017-06-21
US62/523,061 2017-06-21
US15/671,086 2017-08-07
US15/671,086 US10174302B1 (en) 2017-06-21 2017-08-07 Modified L-asparaginase
PCT/EP2018/066647 WO2018234492A1 (en) 2017-06-21 2018-06-21 L-ASPARAGINASE MODIFIED

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023030460A Division JP7770352B2 (ja) 2017-06-21 2023-02-28 修飾されたl-アスパラギナーゼ

Publications (4)

Publication Number Publication Date
JP2020528743A JP2020528743A (ja) 2020-10-01
JPWO2018234492A5 JPWO2018234492A5 (https=) 2025-05-08
JP2020528743A5 JP2020528743A5 (https=) 2025-05-08
JP7808424B2 true JP7808424B2 (ja) 2026-01-29

Family

ID=64737515

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019571042A Active JP7808424B2 (ja) 2017-06-21 2018-06-21 修飾されたl-アスパラギナーゼ
JP2023030460A Active JP7770352B2 (ja) 2017-06-21 2023-02-28 修飾されたl-アスパラギナーゼ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023030460A Active JP7770352B2 (ja) 2017-06-21 2023-02-28 修飾されたl-アスパラギナーゼ

Country Status (15)

Country Link
EP (2) EP3642340B1 (https=)
JP (2) JP7808424B2 (https=)
KR (1) KR102727396B1 (https=)
CN (1) CN111315878B (https=)
AU (1) AU2018287145B2 (https=)
BR (1) BR112019027479A2 (https=)
CA (1) CA3068100A1 (https=)
DK (1) DK3642340T3 (https=)
ES (1) ES2979314T3 (https=)
FI (1) FI3642340T3 (https=)
IL (1) IL271504B2 (https=)
MX (2) MX2019015502A (https=)
SA (2) SA519410870B1 (https=)
SG (1) SG11201912625QA (https=)
WO (1) WO2018234492A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2877539T3 (es) 2015-12-22 2021-11-17 Xl Protein Gmbh Acidos nucleicos que codifican secuencias repetitivas de aminoácidos ricos en residuos de prolina y alanina que tienen bajas secuencias de nucleótidos repetitivas
US12186296B1 (en) 2016-07-22 2025-01-07 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602513B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11986451B1 (en) 2016-07-22 2024-05-21 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
UY37341A (es) 2016-07-22 2017-11-30 Flamel Ireland Ltd Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada
US11602512B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11504347B1 (en) 2016-07-22 2022-11-22 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US12478604B1 (en) 2016-07-22 2025-11-25 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
IL271504B2 (en) * 2017-06-21 2024-05-01 Jazz Pharmaceuticals Ireland Ltd Modified l-asparaginase
WO2019101308A1 (en) * 2017-11-22 2019-05-31 Merz Pharma Gmbh & Co. Kgaa Novel recombinant botulinum toxin with increased duration of effect
CN113473980A (zh) 2019-03-01 2021-10-01 弗拉梅尔爱尔兰有限公司 在进食状态下具有改善的药代动力学的γ-羟基丁酸酯组合物
JP2022553399A (ja) * 2019-10-25 2022-12-22 ジャズ ファーマシューティカルズ アイルランド リミテッド 組換えl-アスパラギナーゼ
US20220227805A1 (en) * 2020-12-23 2022-07-21 Jazz Pharmaceuticals Ireland Ltd. Methods of purifying charge-shielded fusion proteins
WO2022211829A1 (en) 2021-03-30 2022-10-06 Jazz Pharmaceuticals Ireland Ltd. Dosing of recombinant l-asparaginase
US11583510B1 (en) 2022-02-07 2023-02-21 Flamel Ireland Limited Methods of administering gamma hydroxybutyrate formulations after a high-fat meal
US11779557B1 (en) 2022-02-07 2023-10-10 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
WO2024015529A2 (en) 2022-07-14 2024-01-18 Jazz Pharmaceuticals Ireland Ltd. Combination therapies involving l-asparaginase

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012532185A (ja) 2009-07-06 2012-12-13 アリゼ ファーマ トゥー ペグ化されたl−アスパラギナーゼ
JP2013531480A (ja) 2010-05-21 2013-08-08 エクスエル‐プロテイン ゲーエムベーハー プロリン/アラニンランダムコイルポリペプチドの生合成およびその使用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
DE3675588D1 (de) 1985-06-19 1990-12-20 Ajinomoto Kk Haemoglobin, das an ein poly(alkenylenoxid) gebunden ist.
GB8519753D0 (en) * 1985-08-06 1985-09-11 Health Lab Service Board Production of 1-asparaginase
GB9017002D0 (en) * 1990-08-02 1990-09-19 Health Lab Service Board Improved method for the purification of erwina l-asparaginase
US7985548B2 (en) 2006-03-03 2011-07-26 The United States Of America As Represented By The Department Of Health And Human Services Materials and methods directed to asparagine synthetase and asparaginase therapies
US7666652B2 (en) * 2007-03-09 2010-02-23 Novozymes A/S Asparaginases
ATE502114T1 (de) 2007-06-21 2011-04-15 Univ Muenchen Tech Biologisch aktive proteine mit erhöhter in-vivo- und/oder in-vitro-stabilität
CN117462693A (zh) 2012-02-27 2024-01-30 阿穆尼克斯运营公司 Xten缀合组合物和制造其的方法
IL271504B2 (en) 2017-06-21 2024-05-01 Jazz Pharmaceuticals Ireland Ltd Modified l-asparaginase

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012532185A (ja) 2009-07-06 2012-12-13 アリゼ ファーマ トゥー ペグ化されたl−アスパラギナーゼ
JP2013531480A (ja) 2010-05-21 2013-08-08 エクスエル‐プロテイン ゲーエムベーハー プロリン/アラニンランダムコイルポリペプチドの生合成およびその使用

Also Published As

Publication number Publication date
CN111315878A (zh) 2020-06-19
EP4180525A1 (en) 2023-05-17
SA522433360B1 (ar) 2024-06-23
ES2979314T3 (es) 2024-09-25
RU2020101972A (ru) 2021-07-21
AU2018287145B2 (en) 2024-04-18
JP2020528743A (ja) 2020-10-01
RU2020101972A3 (https=) 2021-11-09
WO2018234492A1 (en) 2018-12-27
EP3642340B1 (en) 2024-03-20
JP7770352B2 (ja) 2025-11-14
KR20200030065A (ko) 2020-03-19
SG11201912625QA (en) 2020-01-30
IL271504B1 (en) 2024-01-01
KR102727396B1 (ko) 2024-11-08
MX2019015502A (es) 2020-07-28
CA3068100A1 (en) 2018-12-27
SA519410870B1 (ar) 2023-03-06
AU2018287145A1 (en) 2020-02-06
FI3642340T3 (fi) 2024-06-18
DK3642340T3 (da) 2024-06-03
IL271504B2 (en) 2024-05-01
CN111315878B (zh) 2024-04-26
JP2023081915A (ja) 2023-06-13
EP3642340A1 (en) 2020-04-29
IL271504A (en) 2020-02-27
MX2024015050A (es) 2025-01-09
BR112019027479A2 (pt) 2020-09-15

Similar Documents

Publication Publication Date Title
JP7770352B2 (ja) 修飾されたl-アスパラギナーゼ
US11802279B2 (en) Modified L-asparaginase
EP3418383A1 (en) Modified l-asparaginase
US12441992B2 (en) Method of treating AML with PEGylated l-asparaginase
EP2451486B1 (en) Pegylated l-asparaginase
EP4015526A1 (en) Recombinant interleukin-15 analog
WO2008145013A1 (zh) 包含cd13靶向肽和力达霉素的融合蛋白
RU2775696C2 (ru) Модифицированная l-аспарагиназа
HK40090811A (en) Modified l-asparaginase
HK40029594B (en) Modified l-asparaginase
HK40029594A (en) Modified l-asparaginase

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210531

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220328

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20220330

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220627

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20221028

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230228

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20230228

C11 Written invitation by the commissioner to file amendments

Free format text: JAPANESE INTERMEDIATE CODE: C11

Effective date: 20230308

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20230418

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20230419

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20230428

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250127

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250225

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250305

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20250424

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251031

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20260119

R150 Certificate of patent or registration of utility model

Ref document number: 7808424

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150